We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hikma Pharmaceuticals Plc | LSE:HIK | London | Ordinary Share | GB00B0LCW083 | ORD SHS 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
59.00 | 3.18% | 1,913.00 | 1,916.00 | 1,918.00 | 1,920.00 | 1,861.00 | 1,861.00 | 522,491 | 16:35:11 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 2.88B | 192M | 0.8685 | 22.08 | 4.24B |
Date | Subject | Author | Discuss |
---|---|---|---|
09/5/2022 10:05 | Barclays BUY 2800p target still cheap, if we doubled from here forecast p.e still only around 20. | montyhedge | |
06/5/2022 16:57 | I hope you’re being paid to plug this, and in shares! | blue59 | |
06/5/2022 16:44 | 2800p price target for Hikma by Barclays. | montyhedge | |
06/5/2022 16:38 | Barclays saying nearly 40% rise potential for Hikma.I reckon that's still to cheap.https://www.di | montyhedge | |
06/5/2022 09:47 | You’re like a scratched 78! | blue59 | |
06/5/2022 09:30 | On the RSI Index Hikma has most oversold, lol, I could have told them that.Still buybacks more shares can be bought. | montyhedge | |
06/5/2022 08:08 | Cliff after cliff! | blue59 | |
05/5/2022 18:04 | Tread carefully | volvo | |
05/5/2022 16:36 | P/E ~ 11 for a pharmaceutical company with a solid balance sheet with growth areas seems very low. | justiceforthemany | |
05/5/2022 13:21 | Wrong yet again Monty I must say you are a very useful contra bellwether | phillis | |
05/5/2022 11:53 | 10% share price fall seems very harsh for these revenues moving out perhaps 2-3 months! | adamb1978 | |
05/5/2022 11:02 | Serial disappointment. The last one was About the GSK drug thingee.The CEO is well regarded so we'll see what happens | robertball | |
05/5/2022 09:39 | Market always overdo it on the downside and upside.Like I said never ever thought I would see forecast p.e 10.7 for Hikma. | montyhedge | |
05/5/2022 09:25 | While sentiment is generally against this stock, any little wobble will knock the price down far more than an equivalent bit of good news will raise it. Sentiment will turn whenever it deigns to. | mjneish | |
05/5/2022 09:24 | Looks to be a bit of a timing issue - so imo the fall looks overly harsh. But who knows - this share has been hammered since the end of last year. Suet | suetballs | |
05/5/2022 09:07 | Cant fall much further surely | scepticalinvestor | |
05/5/2022 09:07 | Added at 1660 | scepticalinvestor | |
05/5/2022 09:01 | Not really | robertball | |
05/5/2022 08:53 | Good grief, basket case | scepticalinvestor | |
05/5/2022 08:08 | Never thought I would see Hikma forecast p.e 10.7. Well at least more shares for them in the buybacks. | montyhedge | |
05/5/2022 08:07 | The FT just said that share price subdues due to slow generics. | robertball | |
05/5/2022 07:53 | Nope sorry that was wrong It was unchanged | netcurtains | |
05/5/2022 07:46 | Lower generics guidance for 2022 this am - not good with the share price already severely depressed. Suet | suetballs | |
04/5/2022 08:25 | Do we know the reason for recent big falls? What did the FT comment say? Thanks for any info. Cheers Net. | netcurtains | |
30/4/2022 08:06 | As per FT comment today | robertball |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions